Early Access

10-QPeriod: Q3 FY2022

3M CO Quarterly Report for Q3 Ended Sep 30, 2022

Filed October 25, 2022For Securities:MMM

Summary

3M Company's Q3 2022 report shows a significant increase in net income attributable to 3M, driven by a substantial gain on the split-off of its Food Safety business with Neogen Corporation. This one-time gain largely offsets the operational challenges and increased litigation-related expenses impacting various segments. While net sales saw a slight decline year-over-year, primarily due to divestitures and unfavorable foreign exchange rates, organic sales showed resilience in certain segments. The company continues to navigate complex legal and environmental challenges, notably the ongoing Combat Arms Earplugs litigation and extensive PFAS-related liabilities, which contributed significantly to 'Corporate special items' and impacted operating income. These liabilities represent a material ongoing concern for investors. Despite these headwinds, 3M is strategically moving forward with the planned spin-off of its Health Care business, aiming to create two more focused entities.

Financial Statements
Beta
Revenue$8.62B
Cost of Revenue$4.73B
Gross Profit$3.89B
SG&A Expenses$2.00B
Operating Expenses$4.46B
Operating Income$4.16B
Interest Expense$106.00M
Net Income$3.86B
EPS (Basic)$6.79
EPS (Diluted)$6.77
Shares Outstanding (Basic)568.80M
Shares Outstanding (Diluted)570.00M

Key Highlights

  • 1Net income attributable to 3M surged to $3.86 billion in Q3 2022, a significant increase from $1.43 billion in Q3 2021, largely due to a $2.7 billion pre-tax gain from the Food Safety business split-off.
  • 2Total net sales decreased by 3.6% to $8.62 billion in Q3 2022 compared to $8.94 billion in Q3 2021, impacted by divestitures and foreign exchange headwinds.
  • 3Organic sales increased by 2.0% in Q3 2022, indicating underlying demand resilience despite macroeconomic pressures.
  • 4The company recorded substantial 'Corporate special items' totaling $2.32 billion in Q3 2022, primarily driven by $1.2 billion in charges related to the Combat Arms Earplugs litigation and a $1.09 billion charge for exiting Russia, partially offset by the gain on business divestitures.
  • 5Safety and Industrial segment's operating income increased by 15.9% to $652 million, driven by pricing actions and cost discipline, though sales declined 3.7%.
  • 6The Health Care segment experienced an 11.3% decrease in operating income to $452 million, despite a 1.7% organic sales increase, due to increased costs and investments.
  • 73M announced its intention to spin off its Health Care business into a separate public company, expected to be completed by year-end 2023.

Frequently Asked Questions